Insider Trading History of Bridgebio Pharma, Inc.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bridgebio Pharma, Inc. since year 2005. The trader's CIK number is 1743881. At the time of the last reporting, Bridgebio Pharma, Inc. was the 10% Owner of Eidos Therapeutics, Inc. . (stock ticker symbol EIDX). See this page for all insider trading activities at Eidos Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Bridgebio Pharma, Inc. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-07-03 EIDX Eidos Therapeutics, Inc. Buy 882,353 29.90 26,383,237
2019-05-24 EIDX Eidos Therapeutics, Inc. Buy 1,103,848 25.93 28,622,778
2018-12-10 EIDX Eidos Therapeutics, Inc. Sale 40,653 13.62 553,897
2018-12-06 EIDX Eidos Therapeutics, Inc. Sale 38,970 13.34 519,859
2018-12-07 EIDX Eidos Therapeutics, Inc. Sale 41,174 14.15 582,612
2018-12-05 EIDX Eidos Therapeutics, Inc. Buy 1,103,848 14.01 15,464,910
2018-12-03 EIDX Eidos Therapeutics, Inc. Buy 1,750,000 15.50 27,125,000
2018-06-22 EIDX Eidos Therapeutics, Inc. Buy 1,000,000 17.00 17,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bridgebio Pharma, Inc. (10% Owner of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.